MHRA website >
There are increasing regulations and
pressures from shippers to ensure the
safe carriage of pharmaceutical products. At
the recent Life Sciences and Pharmaceutical
conference in London, it was made clear that
logistics firms will have to comply with the new
regulations in place.
Logistics companies transporting or holding
medicines for people or animals, may need
to attain Wholesale Distribution Authorisation
(WDA) from the UK's Medicines and
Healthcare Products Regulatory Agency
(MHRA), or ensure relevant parties in the
supply chain are compliant.
MHRA Inspector, Cheryl Blake, warned
forwarders, handlers and carriers that they may
have to comply with this rule. She confirmed
that any UK company exporting, holding or
storing medicines needs a WDA. This includes
freight consolidators or forwarders, Customs
sheds and bonded facilities.
"Transport, ie moving without storing for
unjustified periods of time, does not need a
WDA," she explained. "We are not trying to
bury you in paperwork, and it is unlikely that a
forwarder will require a WDA unless they are
'holding' a product."
WHY ALL THE RULES?
combine ingredients precisely,
under specific conditions, while
negotiating a maze of stringent
regulations and quality controls.
Companies that move or store
pharmaceutical products must
meet similar demands:
n Many drugs are highly sensitive
n Some drugs are extremely
n All are subject to a complex
array of government regulations